TCL Archive Board Defers core Guideline changes, Asks Subcommittee For Alternate Plans November 18, 1977
TCL Archive Health Care Delivery: Value Of Informatics To PPMs Is a Message for Academic Centers November 22, 1996
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
